AU520682B2 - Lipogensis inhibitors - Google Patents

Lipogensis inhibitors

Info

Publication number
AU520682B2
AU520682B2 AU37515/78A AU3751578A AU520682B2 AU 520682 B2 AU520682 B2 AU 520682B2 AU 37515/78 A AU37515/78 A AU 37515/78A AU 3751578 A AU3751578 A AU 3751578A AU 520682 B2 AU520682 B2 AU 520682B2
Authority
AU
Australia
Prior art keywords
lipogensis
inhibitors
lipogensis inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU37515/78A
Other languages
English (en)
Other versions
AU3751578A (en
Inventor
D. T. Carr J. B. and Leesmann H. J Witiak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shell Internationale Research Maatschappij BV
Original Assignee
Shell Internationale Research Maatschappij BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shell Internationale Research Maatschappij BV filed Critical Shell Internationale Research Maatschappij BV
Publication of AU3751578A publication Critical patent/AU3751578A/en
Application granted granted Critical
Publication of AU520682B2 publication Critical patent/AU520682B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/008—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with tri- or tetrahalomethyl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AU37515/78A 1977-06-30 1978-06-28 Lipogensis inhibitors Expired AU520682B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81164777A 1977-06-30 1977-06-30
USUS811647 1977-06-30
US81789877A 1977-07-21 1977-07-21
USUS817898 1977-07-21

Publications (2)

Publication Number Publication Date
AU3751578A AU3751578A (en) 1980-01-03
AU520682B2 true AU520682B2 (en) 1982-02-18

Family

ID=27123512

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37515/78A Expired AU520682B2 (en) 1977-06-30 1978-06-28 Lipogensis inhibitors

Country Status (9)

Country Link
AU (1) AU520682B2 (da)
DD (1) DD141023A5 (da)
DE (1) DE2828396A1 (da)
DK (1) DK292678A (da)
FR (1) FR2401146A1 (da)
GB (1) GB2007973B (da)
IT (1) IT1113147B (da)
NL (1) NL7806944A (da)
SE (1) SE7807338L (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019955A1 (en) * 1979-05-16 1980-12-10 Shell Internationale Researchmaatschappij B.V. Benzofurancarboxylic acid derivatives, their preparation and their inclusion in lipogenesis inhibiting compositions
US4229467A (en) * 1979-08-16 1980-10-21 Richardson-Merrell Inc. Alkoxy benzofuran carboxylic acids and salts and esters thereof as hypolipidemic agents
EP0146243A1 (en) * 1983-10-31 1985-06-26 Merck Frosst Canada Inc. Lipoxygenase inhibitors
US4933351A (en) * 1983-10-31 1990-06-12 Merck Frosst Canada, Inc. Benzofuran 2-carbox amides useful as inhibitors of leukoriene biosynthesis
US4663347A (en) * 1983-10-31 1987-05-05 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis
US4822803A (en) * 1983-10-31 1989-04-18 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid hydrazides useful as inhibitors of leukotriene biosynthesis
JP3093507B2 (ja) * 1993-02-15 2000-10-03 キヤノン株式会社 液晶性化合物、これを含む液晶組成物、それを有する液晶素子、それらを用いた表示方法および表示装置

Also Published As

Publication number Publication date
FR2401146B1 (da) 1983-03-18
DE2828396A1 (de) 1979-01-11
FR2401146A1 (fr) 1979-03-23
DD141023A5 (de) 1980-04-09
AU3751578A (en) 1980-01-03
SE7807338L (sv) 1978-12-31
NL7806944A (nl) 1979-01-03
IT1113147B (it) 1986-01-20
GB2007973B (en) 1982-04-21
IT7825091A0 (it) 1978-06-28
DK292678A (da) 1978-12-31
GB2007973A (en) 1979-05-31

Similar Documents

Publication Publication Date Title
AU3409978A (en) 4-acylaminophenyl-ethanolamines
AU3506678A (en) Polyetheramide-acids
AU3662478A (en) Pyridobenzodiazepines
AU3069177A (en) Inkduct
AU3780378A (en) Circuit-tester
AU3347978A (en) Phenyl-benzimidazoyl-furanes
AU3770478A (en) 3-indolyl-tertiary butylaminopropanole
AU3662278A (en) Pyridobenzoiazepines
AU3216478A (en) Phenylcarbamoyl-2-pyrazolines
AU3216278A (en) Phenylcarbamoyl-pyrazolines
AU3732478A (en) a-ETHYNYL TRYTOPHANES
AU514558B2 (en) Scale inhibitors
AU3239278A (en) Dithienylalkylamines
AU520682B2 (en) Lipogensis inhibitors
AU3307178A (en) Chloroacetanylides
AU3401278A (en) Sipper-seal
AU3821078A (en) Imidazo-isoquinoline-diones
AU3492478A (en) 4-alkylthio-2-trifluoromethylalkanesulfonides
AU3815178A (en) 7a-Methoxycephalosporins
AU3764478A (en) Benzylpyrimidines
AU4242078A (en) 1-halogeno-1-propyn-3-ols
AU3418778A (en) Hydroxylated-1d-2d-methylene-steroids
AU3732678A (en) Alpha-vinyl tryptophanes
AU3706678A (en) Pyridazinylhydrazines
AU3790378A (en) Amidino-benzylpyrimidines